On Monday evening in a charity auction at Christie’s, Andy Warhol’s 1964 silk-screen of Marilyn Monroe, “Shot Sage Blue Marilyn,” is estimated to sell for about $200 million.
NEW YORK — In 1985, dealer Tony Shafrazi designed a poster promoting his show of paintings made jointly by Andy Warhol and Jean-Michel Basquiat. The image featured the two artists in boxing gloves as if preparing to spar with each other.
“There’s been a huge amount held back for two years, and there’s a huge amount of pent-up demand from new clients,” said Philip Hoffman, founder of The Fine Art Group, a New York-based advisory company, adding that the upcoming auctions could raise as much as $2 billion. “Everyone was waiting for the right moment, and the right moment has come.”
The painting was in the collection of Swiss dealers Thomas and Doris Ammann, and the proceeds from Monday’s sale of 36 works will go to their foundation, which supports children’s programs. In an unusual arrangement, the buyer will have a say in choosing which charity that 20% of the proceeds are allocated, Christie’s announced Sunday.
Striking for its bright-blue eye shadow, yellow hair and red lips, the work had been exhibited at institutions including the Guggenheim in New York, the Centre Georges Pompidou in Paris and Tate Modern in London.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Warhol Monroe portrait set to smash records at New York salesAn Andy Warhol portrait of Marilyn Monroe worth an estimated $200 million headlines this month's spring sales in New York that collectors say are among the most anticipated ever.
Read more »
Creating a cultural hub: UC San Diego opens Park & Market downtownThe $60-million project promises to enhance education, business, art and ideas throughout the region
Read more »
Commentary: An Ohio museum is holding the biggest sale of museum art yet. It's unconscionableThe Toledo Museum of Art, which is monetizing more than $60 million of collection art, joins a troubling trend of museums deaccessioning work that's long been in the public realm.
Read more »
FDA approves marketing for new Alzheimer's early detection testThe Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline.
Read more »